U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
101011101011Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Real-World Patient Population in ChinaActive, not recruitingNo Results AvailableIschemic Heart Disease|Stenotic Coronary Lesion|Cardiovascular Diseases|Arteriosclerosis|Coronary Artery Diseasehttps://ClinicalTrials.gov/show/NCT01243749
101012101012Assessment of Combined Bowel Preparation for Capsule Endoscopy StudyCompletedNo Results AvailableGastrointestinal HemorrhageDrug: Combination Prephttps://ClinicalTrials.gov/show/NCT01243736
101013101013Study Assessing the Efficacy of Eductyl® for the Treatment of Patients With DyschesiaCompletedNo Results AvailableDyschesiaDrug: Eductyl suppository|Drug: Placebo suppositoryhttps://ClinicalTrials.gov/show/NCT01243723
101014101014Taurolidine in Haemodialysis Catheter Related BacteraemiaCompletedNo Results AvailableRenal Dialysis|Catheter-Related InfectionsDevice: Taurolidine with heparin (500 units/ ml)https://ClinicalTrials.gov/show/NCT01243710
101015101015Assessment of Desogestrel in Ondine SyndromeCompletedNo Results AvailableOndine SyndromeDrug: desogestrelhttps://ClinicalTrials.gov/show/NCT01243697
101016101016A Magnetic Resonance Imaging Study of Patients With Cervical SpondylosisActive, not recruitingNo Results AvailableCervical SpondylosisDevice: DTI - Diffusor Tensor Imaginghttps://ClinicalTrials.gov/show/NCT01243684
101017101017A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's DiseaseCompletedHas ResultsIntestinal Behçet's DiseaseBiological: Adalimumabhttps://ClinicalTrials.gov/show/NCT01243671
101018101018"The Effects of Oxytocin on Patients With Borderline Personality Disorder"RecruitingNo Results AvailableEffects of Oxytocin on Borderline Personality Disorder.Drug: Oxytocinhttps://ClinicalTrials.gov/show/NCT01243658
101019101019MP-1 Biofeedback: Pattern Stimulus Versus Audio-feedback in AMDCompletedNo Results AvailableAge Related Macular DegenerationBehavioral: biofeedback traininghttps://ClinicalTrials.gov/show/NCT01243645
101020101020Gemcitabine in Long Infusion and Cisplatin for Malignant Pleural Mesothelioma TreatmentCompletedNo Results AvailableMalignant Pleural MesotheliomaDrug: Prolonged 6-hr infusion of gemcitabinehttps://ClinicalTrials.gov/show/NCT01243632
101021101021FLT PET/CT for Staging, Target Definition and Assessment of Response to Therapy in Patients With Esophageal CancerActive, not recruitingHas ResultsEsophageal CancerDrug: 3'-deoxy-3'-(18) F-fluorothymidinehttps://ClinicalTrials.gov/show/NCT01243619
101022101022Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety DisordersActive, not recruitingNo Results AvailableAnxiety Disorders|Mood DisordersBehavioral: Single Diagnosis Treatment Protocol|Behavioral: Unified Protocol (UP)https://ClinicalTrials.gov/show/NCT01243606
101023101023Transversus Abdominis Plane Block in Children Undergoing Open Pyeloplasty SurgeryCompletedNo Results AvailableAnesthesiaProcedure: Transversus Abdominis Plane Block|Procedure: Standard Anesthesiahttps://ClinicalTrials.gov/show/NCT01243593
101024101024AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl EstradiolCompletedNo Results AvailableHealthyDrug: Ortho-Cyclen (r)|Drug: AG200-15 containing LNG and EEhttps://ClinicalTrials.gov/show/NCT01243580
101025101025Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been TreatedCompletedHas ResultsGlaucoma, Open-AngleDrug: bimatoprost 0.03%/timolol 0.5% combination ophthalmic solution|Drug: latanoprost 0.005% ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT01243567
101026101026Exercise Training in Pregnancy for Obese MothersRecruitingNo Results AvailablePregnancy|ObesityBehavioral: Exercisehttps://ClinicalTrials.gov/show/NCT01243554
101027101027Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving PaclitaxelActive, not recruitingNo Results AvailableChemotherapeutic Agent Toxicity|Pain|Peripheral Neuropathy|Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer|Stage IV Breast Cancer|TheraProcedure: cryotherapy|Other: questionnaire administration|Procedure: quality-of-life assessment|Procedure: management of therapy complications|Procedure: assessment of therapy complicationshttps://ClinicalTrials.gov/show/NCT01243541
101028101028Observational Study at the Influence of Malnutrition on InfectionsCompletedNo Results AvailableMalnutritionOther: Laboratory valueshttps://ClinicalTrials.gov/show/NCT01243528
101029101029Comparison of a Non-Invasive Central Venous Pressure Device and Physical Examination in Patients With Chronic Kidney DiseaseWithdrawnNo Results AvailableCentral Venous PressureDevice: Non-Invasive Central Venous Pressure monitor|Procedure: Physical examination of jugular veinhttps://ClinicalTrials.gov/show/NCT01243515
101030101030A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male VolunteersCompletedNo Results AvailableSafetyDrug: 0.01% CT327 (or placebo)|Drug: 0.001% CT327 (or placebo)https://ClinicalTrials.gov/show/NCT01243502
101031101031Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND OptimisationActive, not recruitingNo Results AvailableChronic Myelogenous Leukemia (CML)Other: compliance supporting measureshttps://ClinicalTrials.gov/show/NCT01243489
101032101032Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic SyndromeRecruitingNo Results AvailableMyelodysplastic SyndromeDrug: Lenalidomide|Other: Placebohttps://ClinicalTrials.gov/show/NCT01243476
101033101033Bariatric Surgery and Obstructive Sleep ApneaCompletedNo Results AvailableObstructive Sleep Apnea|Bariatric Surgeryhttps://ClinicalTrials.gov/show/NCT01243463
101034101034Bioequivalence Study of Generic Tretinoin 0.04% Microsphere Gel, 0.04% Retin-A Micro® and PlaceboCompletedHas ResultsAcneDrug: Tretinoin|Drug: placebohttps://ClinicalTrials.gov/show/NCT01243450
101035101035A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in HumansRecruitingNo Results AvailablePlagueDrug: ciprofloxacin|Drug: doxyxcyclinehttps://ClinicalTrials.gov/show/NCT01243437
101036101036CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesActive, not recruitingNo Results AvailableDiabetes Mellitus, Type 2Drug: linagliptin|Drug: glimepiride|Drug: linagliptin placebo|Drug: glimepride placebohttps://ClinicalTrials.gov/show/NCT01243424
101037101037A Study of AA4500 in Men With Peyronie's DiseaseCompletedHas ResultsPeyronie's DiseaseBiological: AA4500https://ClinicalTrials.gov/show/NCT01243411
101038101038Gefitinib in Treating Patients With Esophageal Cancer That is Progressing After ChemotherapyCompletedNo Results AvailableAdenocarcinoma of the Gastroesophageal Junction|Esophageal CancerProcedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT01243398
101039101039Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate CancerActive, not recruitingNo Results AvailableProstate CancerDrug: metformin hydrochloridehttps://ClinicalTrials.gov/show/NCT01243385
101040101040Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal CancerActive, not recruitingNo Results AvailableColorectal CancerGenetic: mutation analysis|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01243372

* Görseller ve İçerik tekif hakkına sahip olabilir